FDA Inspection
Merck & Co. IncMerck & Co. Inc – FDA Inspection, Sep 6, 2019
Record Details
This FDA Inspection record concerns Merck & Co. Inc, with an inspection on September 6, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 64a70c11-e5e9-499f-bbb8-71fe4817fc59
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1101464
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.56(b)Notification of FDA of termination of investigator
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Merck & Co. Inc
15| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2026 | Not classified | New Jersey District Office | |
| March 13, 2026 | Not classified | New Jersey District Office | |
| December 18, 2025 | Not classified | New Jersey District Office | |
| May 16, 2025 | Not classified | New Jersey District Office | |
| March 27, 2025 | Not classified | New Jersey District Office |
Other documents for Merck & Co. Inc
- FDA Inspection 1329118 - 2026-08-14
- FDA Inspection 1305632 - 2026-03-13
- FDA Inspection 1283890 - 2025-12-18
- FDA Inspection 1262774 - 2025-05-16
- FDA Inspection 1264192 - 2025-03-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.